R. Kohansal (Vienna, Austria)
A nurse led community respiratory assessment and management service (CRAMS): assessing long term oxygen therapy (LTOT) in the community
D. Wood, S. Haggerty, V. Hall, N. Keaney (Hartlepool, United Kingdom)
|  |
Use and utility of an early presentation and intervention in COPD (EPIC) service
J. R. Hurst, F. Fitzgerald-Khan, J. P. Dilworth, C. Mikelsons, J. A. Wedzicha (Royal Free Campus, London, United Kingdom)
| |
End of life care in COPD: current practise and clinical indicators of end-stage disease
H. Haja Mydin, S. Fatah, G. Antunes, S. Murphy (Middlesbrough, United Kingdom)
|  |
Early supported discharge schemes in older patients with an exacerbation of chronic obstructive pulmonary disease: a real life experience
D. Miller, G. Douglas, M. Strachan, J. Fiddes, G. Currie (Aberdeen, United Kingdom)
| |
Characteristics of COPD patients with a high consumption of health-care resources
C. Garcia Polo, A. Herrejon Silvestre, J. A. Ros Lucas, L. A. Ruiz, G. Tirado Conde, C. Martinez Ribera, P. Garcia Sidro, M. Miravitlles, InEPOC Group (Cádiz, Spain)
| |
Oxygen prescription and administration audit at a UK teaching hospital: compliance with British thoracic society (BTS) guidelines and the impact of electronic prescribing
J. Winston, J. Robinson, A. James, S. Burge (Birmingham, United Kingdom)
| |
AUDIPOC. National clinical audit on chronic obstructive pulmonary disease exacerbations (eEPOC) in Spain. Mortality and readmission at 90 days of patients admitted for eEPOC. Influence of hospitalization department
C. Hernandez, C. J. Alvarez, C. Melero, R. Agüero, J. Hueto, M. Barron, G. Aranda, F. Pozo (Barcelona, Madrid, Santander.Cantabria, Navarra, Logroño.La Rioja, Spain)
| |
A clinical audit of COPD-hospitalizations in three Scandinavian hospitals
E. D. Liaaen, A. H. Henriksen, N. Stenfors (Aalesund, Trondheim, Norway; Östersund, Sweden)
| |
Public awareness of COPD
I. Jarrold, J. Morrell, N. Eiser (London, United Kingdom)
| |
Are there clinical differences in COPD patients between primary care and pulmonology?
D. De la Rosa, N. Roldan, A. Ocanya, Y. Maltas, C. Roca, M. Gomez, E. Barbeta, N. Montella (Barcelona, El Masnou, Badalona, Granollers, Spain)
| |
Adherence to GOLD guidelines and health-related quality of life in outpatients with COPD
C. Dimitropoulos, K. Kotsifas, E. Theodorakopoulou, G. Alexias, E. Kosmas, I. Ntanos (Athens, Greece)
| |
The study of influence of different bronchodilatators in the patients with exacerbation of chronic obstructive disease (COPD) and benign prostatic hyperplasia (bph)
N. Berdnikova, D. Tsiganko, M. Averyianov (Moscow, Russian Federation)
| |
A heat and moisture exchange mask improves cardiopulmonary function in COPD patients during cold exposure
J. Seifert (Bozeman, United States Of America)
| |
Randomised, double-blind, placebo-controlled trial of EPS® 7630 in adults with COPD
H. Matthys, D. A. Pliskevich, F. A. Malek, M. Tribanek, M. Kieser (Freiburg i. Br., Karlsruhe, Heidelberg, Germany; Kiev, Ukraine)
| |
Influence of tiotropium bromide (TB) on mucociliary clearance (MCC) in patients with COPD
T. Pertseva, O. Lykholat, O. Gurzhiy (Dnepropetrovsk, Ukraine)
| |
Benefit of budesonide/formoterol compared with salmeterol/fluticasone in COPD patients in the morning
M. R. Partridge, W. Schuermann, O. Beckman, T. Persson (London, United Kingdom; Marburg, Germany; Lund, Sweden)
| |
Bone mineral density changes in male patients with chronic obstructive pulmonary disease: clinical and biochemical variables in correlation with glucocorticoids use
S. AlSayed, E. Mousa, A. M. Barrak, A. Abulfotoh, M. Rosasy (Egypt)
| |
Niv mortality in clinical practice – the 2008 UK national COPD audit
C. Roberts, R. Buckingham, N. Pursey, D. Lowe, R. Stone (London, United Kingdom)
| |
Critical view on diagnosing muscle wasting by single frequency bio-electrical impedance in COPD
E. Rutten, M. Spruit, E. Wouters (Horn, Maastricht, Netherlands)
| |
Skeletal muscle dysfunction and the related mechanism in chronic obstructive pulmonary disease
C. Ju, R. Chen (Guangzhou, China)
| |